Front Row Advisors’s Vericel Corp VCEL Stock Holding History
Bought
Maintained
Sold
Other funds holding VCEL
BCM
CCA
CAM
GKIM
Front Row Advisors's VCEL Position: Q3 2024 in Review
Front Row Advisors sold out of Vericel Corp (VCEL) in Q3 2024, closing a stake of 104 shares — an estimated $4.77K sold.
Front Row Advisors first reported a position in VCEL in Q1 2022 and held it in 9 quarters. The position peaked at $6.35K in Q1 2024. 268 funds tracked by Wall St. Rank hold VCEL as of Q3 2024.
- Front Row Advisors reported no remaining Vericel Corp position as of Q3 2024 after selling out during the quarter.
- Front Row Advisors sold 104 Vericel Corp shares in Q3 2024, an estimated $4.77K.
- Front Row Advisors first reported a position in Vericel Corp in Q1 2022 and held it in 9 quarters.
- Front Row Advisors's Vericel Corp position peaked at $6.35K in Q1 2024.
- 268 funds tracked by Wall St. Rank held Vericel Corp as of Q3 2024.
Based on Front Row Advisors's 13F filing for Q3 2024, filed 14 Nov 2024.